Clinical characteristics and outcome for hepatitis C virus-positive diffuse large B-cell lymphoma

References

• Gasparotto D, De Re V, Boiocchi M. Hepatitis C virus, B-cell proliferation and lymphomas. Leuk Lymphoma 2002; 43: 747–751
   PubMed Web of Science ®Google Scholar
• Gisbert J P, Garcia-Buey L, Arranz R, Blas C, Pinilla I, Khorrami S, et al. The prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Eur J Gastroenterol Hepatol 2004; 16: 135–138
   PubMed Web of Science ®Google Scholar
• Matsuo K, Kusano A, Sugumar A, Nakamura S, Tajima K, Mueller N E. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies. Cancer Sci 2004; 95: 745–752
   PubMed Web of Science ®Google Scholar
• Mazzaro C, Tirelli U, Pozzato G. Hepatitis C virus and non-Hodgkin's lymphoma 10 years later. Dig Liver Dis 2005; 37: 219–226
   PubMedGoogle Scholar
• Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi S. B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review. Int J Cancer 2004; 111: 1–8
   PubMed Web of Science ®Google Scholar
• Gisbert J P, Garcia-Buey L, Pajares J M, Moreno-Otero R. Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection. Aliment Pharmacol Ther 2005; 21: 653–662
   PubMed Web of Science ®Google Scholar
• Ivanovski M, Silvestri F, Pozzato G, Anand S, Mazzaro C, Burrone O R, et al. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 1998; 91: 2433–2442
   PubMed Web of Science ®Google Scholar
• Quinn E R, Chan C H, Hadlock K G, Foung S K, Flint M, Levy S. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 2001; 98: 3745–3749
   PubMed Web of Science ®Google Scholar
• Sung V M, Shimodaira S, Doughty A L, Picchio G R, Can H, Yen T S, et al. Establishment of B-cell lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection. J Virol 2003; 77: 2134–2146
   PubMed Web of Science ®Google Scholar
• De Vita S, Sacco C, Sansonno D, Gloghini A, Dammacco F, Crovatto M, et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 1997; 90: 776–782
   PubMed Web of Science ®Google Scholar
• Luppi M, Longo G, Ferrari M G, Barozzi P, Marasca R, Morselli M, et al. Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia. Ann Oncol 1998; 9: 495–498
   PubMed Web of Science ®Google Scholar
• Visco C, Arcaini L, Brusamolino E, Burcheri S, Ambrosetti A, Merli M, et al. Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy. Ann Oncol 2006; 17: 1434–1440
   PubMed Web of Science ®Google Scholar
• Besson C, Canioni D, Lepage E, Pol S, Morel P, Lederlin P, et al. Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs. J Clin Oncol 2006; 24: 953–960
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Harris N L, Stein H, Vardiman J W. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. World Health Organization Classification of Tumours. IARC Press, LyonFrance 2001
   Google Scholar
• Cheson B D, Horning S J, Coiffier B, Shipp M A, Fisher R I, Connors J M, et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244
   PubMed Web of Science ®Google Scholar
• Gisbert J P, Garcia-Buey L, Pajares J M, Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 2003; 125: 1723–1732
   PubMed Web of Science ®Google Scholar
• Mazzaro C, Zagonel V, Monfardini S, Tulissi P, Pussini E, Fanni M, et al. Hepatitis C virus and non-Hodgkin's lymphomas. Br J Haematol 1996; 94: 544–550
   PubMed Web of Science ®Google Scholar
• Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4296–4301
   PubMed Web of Science ®Google Scholar
• Dal Maso L, Franceschi S. Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2006; 15: 2078–2085
   PubMed Web of Science ®Google Scholar
• Nieters A, Kallinowski B, Brennan P, Ott M, Maynadie M, Benavente Y, et al. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH. Gastroenterology 2006; 131: 1879–1886
   PubMed Web of Science ®Google Scholar
• Shin H R. Epidemiology of hepatitis C virus in Korea. Intervirology 2006; 49: 18–22
   PubMed Web of Science ®Google Scholar
• Murphy E L, Bryzman S, Williams A E. Prevalence of hepatitis C virus infection in the United States. N Engl J Med 1999; 341: 2093, author reply 2094 – 2095
   PubMed Web of Science ®Google Scholar
• Reimer J, Schulte B, Castells X, Schafer I, Polywka S, Hedrich D, et al. Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries. Clin Infect Dis 2005; 40(Suppl 5)S373–S378
   PubMed Web of Science ®Google Scholar
• Cho S H, Yoon J I, Chang J E, Ahn B M, Lee C H, Lee Y I. Genomic typing of hepatitis C viruses from Korean patients: implications of genome variation in the E2/NS1 region. Biochem Biophys Res Commun 1993; 196: 780–788
   PubMed Web of Science ®Google Scholar
• De Re V, De Vita S, Marzotto A, Rupolo M, Gloghini A, Pivetta B, et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 2000; 96: 3578–3584
   PubMed Web of Science ®Google Scholar
• Arcaini L, Paulli M, Burcheri S, Rossi A, Spina M, Passamonti F, et al. Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease. Br J Haematol 2007; 136: 301–304
   PubMed Web of Science ®Google Scholar
• Arcaini L, Lazzarino M, Colombo N, Burcheri S, Boveri E, Paulli M, et al. Splenic marginal zone lymphoma: a prognostic model for clinical use. Blood 2006; 107: 4643–4649
   PubMed Web of Science ®Google Scholar